Obsidian Therapeutics Inc. OBX · SEC Filings

website

A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop...

Price13.71

Market Cap846.91 M

Float61.77 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

News

TYPE

HEADLINE

FILED AT

8-K/A

Obsidian Therapeutics Q2 2026 Financial Results and Post-Period $350 Million Financing

Aug 14, 2026

8-K

Obsidian Therapeutics Completes Merger with Galera Therapeutics and $350 Million Private Placement

Aug 3, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

OFFERING - OTHER | Shares: 36,878,144 | Price: $12.000

Jul 2, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-1

SHARE RESALE REGISTRATION

Aug 28, 2026

S-8

Obsidian Therapeutics, Inc. 2016 Stock Option and Grant Plan

Aug 3, 2026

8-A12B/A

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]

Aug 3, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Aug 3, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Jul 2, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Jun 30, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

Paradigm Biocapital Advisors LP (Filed by)

Oct 5, 2026

SCHEDULE 13G

Deep Track Capital, LP (Filed by)

Aug 11, 2026

SCHEDULE 13G

Atlas Venture Fund X, L.P. (Filed by)

Aug 10, 2026

SCHEDULE 13G

RA CAPITAL MANAGEMENT, L.P. (Filed by)

Aug 10, 2026

SCHEDULE 13G

Novo Holdings A/S (Filed by)

Aug 10, 2026

ROSS ROBERT W. (Reporting)

Aug 5, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 10, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 6, 2026